Characteristic | Mean. (SD) / No. (%) | P Value | |
---|---|---|---|
TLS group (n = 36) | HLS group (n = 17) | ||
Age, y | 56.9 ± 8.9 | 58.1 ± 11.4 | 0.691 |
BMI, kg/m2 | 22.6 ± 2.7 | 23.3 ± 2.9 | 0.389 |
Size, cm | 3.9 ± 1.7 | 4.4 ± 2.2 | 0.317 |
Size, cm | 0.126 | ||
≤ 5 | 32 (88.9%) | 12 (70.6%) | |
> 5 | 4 (11.1%) | 5 (29.4%) | |
Sex | 0.111 | ||
Female | 19 (52.8%) | 5 (29.4%) | |
Male | 17 (47.2%) | 12 (70.6%) | |
ASA-PS | 0.789 | ||
1 | 26 (72.2%) | 11 (64.7%) | |
2 | 9 (25.0%) | 5 (29.4%) | |
3 | 1 (2.8%) | 1 (5.9%) | |
Comorbidity | 0.437 | ||
None | 27 (75.0%) | 11 (64.7%) | |
Yes | 9 (25.0%) | 6 (35.3%) | |
Tumor location | 0.032 | ||
Gastric cardia | 5 (13.9%) | 7 (41.2%) | |
Gastric fundus | 8 (22.2%) | 3 (17.7%) | |
Gastric body | 9 (25.0%) | 6 (35.3%) | |
Gastric antrum | 14 (38.9%) | 1 (5.9%) | |
Mitotic count (per 50 HPFs) | 0.713 | ||
≤ 5 | 26 (72.2%) | 14 (82.4%) | |
6–10 | 6 (16.7%) | 2 (11.8%) | |
> 10 | 4 (11.1%) | 1 (5.9%) | |
Modified NIH criteria | 0.473 | ||
Very low risk | 4 (11.1%) | 2 (11.8%) | |
Low risk | 22 (61.1%) | 8 (47.1%) | |
Intermediate risk | 6 (16.7%) | 6 (35.3%) | |
High risk | 4 (11.1%) | 1 (5.9%) |